On December 10, 2020 a
Stipulation,Agreement
was filed
involving a dispute between
Patsy Young,
and
Aventis Inc.,
Avon Products, Inc.,
Block Drug Company, Inc.,
Block Drug Corporation,
Brenntag North America, Inc.,
Brenntag Specialties, Inc. F K A Mineral Pigment Solutions, Inc.,
Charles B. Chrystal Company, Inc.,
Chattem, Inc.,
Colgate-Palmolive Company,
Cyprus Amax Minerals Company,
Cyprus Mines Corporation,
Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A K A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And
Novartis Consumer Health Inc.),
Gsk Consumer Health, Inc. F K A Novartis Consumer Health Inc. F K A Ciba Self-Medication, Inc.,
Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc.,
Insight Pharmaceuticals Llc,
Macy'S Inc. F K A Federated Department Stores, Inc.,
Novartis Pharmaceuticals Corporation,
Prestige Brands Holdings, Inc.,
Prestige Consumer Healthcare Inc. F K A Prestige Brands, Inc.,
Sanofi-Aventis U.S. Llc,
Sanofi Us Services, Inc.,
Whittaker Clark & Daniels, Inc.,
for Torts - Asbestos
in the District Court of Erie County.
Preview
FILED: ERIE COUNTY CLERK 07/12/2021 02:06 PM INDEX NO. 815818/2020
NYSCEF DOC. NO. 29 RECEIVED NYSCEF: 07/12/2021
SUPREME COURT OF THE STATE OF NEW YORK
EIGHTH JUDICIAL DISTRICT
In Re Eighth Judicial District
Asbestos Litigation
This Document Applies to: STIPULATION OF
DISCONTINUANCE
SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF ERIE
PATSY YOUNG, This Stipulation Applies
to Novartis Corporation
Plaintiff, and Novartis
Pharmaceuticals
Corporation, Only
AVENTIS INC., et al Index No. 815818/2020
Defendants.
IT IS HEREBY STIPULA ED AND AGREED, by and between the
undersigned, the attorneys of record for Plaintiff, for Defendant Novartis Corporation,
individually, (incorrectly named and sued herein as "a successor-in-interest to Ciba-Geigy
Corporation and its subsidiaries Ciba Consumer Pharmaceuticals and Ciba Self-Medication,
Inc."), (hereinafter "Novartis"), and for Defendant Novartis Pharmaceuticals Corporation,
individually, (incorrectly named and sued herein as "successor-in-interest to Ciba-Geigy
Corporation and its subsidiary Ciba Consumer Pharmaceuticals"), (hereinafter "NPC"), that
the above-entitled action be, and the same hereby is, discontinued by Plaintiff as against
Novartis and NPC, with prejudice and without costs to either party as against the,other.
This stipulation may be filed without further notice with this Court.
1
1 of 2
FILED: ERIE COUNTY CLERK 07/12/2021 02:06 PM INDEX NO. 815818/2020
NYSCEF DOC. NO. 29 RECEIVED NYSCEF: 07/12/2021
Dated: Buffalo, New York
Juitt 1.2 , 2021
PHILLIPS LYTLE LLP LIPSITZ & PONTERIO, LLC
By: -)11.-ith,t1 ., -e-k By:
Mary o Herrscher Jo14n P. Comer rd
Attorneys for Defendants Attorneys for Plainti
Novartis Corporation and 424 Main Street, Suite 1500
Novartis Pharmaceuticals Corporation Buffalo, New York 14202
One Canalside 716-849-0701
125 Main Street
Buffalo, New York 14203-2887 and
716-847-8400
SIMON G ANAT1ER, PC
By:
S art P dy
erley
Attorneys for Plaintiff
1201 Elm Street, Suite 3400
Dallas, TX 75270
(214) 276-7680
Doc #9781627.1
2
2 of 2
Document Filed Date
July 12, 2021
Case Filing Date
December 10, 2020
Category
Torts - Asbestos
For full print and download access, please subscribe at https://www.trellis.law/.